SAKK 21/12: A stratified, multicenter phase II trial of transdermal CR1447 in endocrine responsive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer
Title:
SAKK 21/12: A stratified, multicenter phase II trial of transdermal CR1447 in endocrine responsive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer
Author:
Vetter, M.H.F. Rothgiesser, K. Li, Q. Hawle, H. Schönfeld, W. Ribi, K. Riniker, S. von Moos, R. Müller, A. Thürlimann, B.